Resource Center
Events
Press Releases
Karius Secures BARDA Contract to Expand Agnostic Detection of Pathogens
Karius Test® Receives FDA Breakthrough Device Designation to Aid in the Diagnosis of Infectious Disease
Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis
Video Library
Clinical Evidence
Peer-reviewed Publications
Search through multiple publications showing the efficacy of the Karius Spectrum test.
Abstracts
View abstracts that evaluated the metagenomic sequencing of the Karius Spectrum test.
Clinical Trials
View clinical trials validating the Karius Spectrum test’s ability to detect pathogens in various clinical contexts.